c="Pompe's disease" 1:12 1:13||t="problem"||cui="C0017921"||tot="Glycogen storage disease type II"||ns="-1000"
c="infantile glycogen storage disease type II" 2:8 2:13||t="problem"||cui="C0751173"||tot="Glycogen Storage Disease Type II, Infantile"||ns="-1000"
c="Pompe's) disease" 2:14 2:15||t="problem"||cui="C0017921"||tot="Glycogen storage disease type II"||ns="-1000"
c="human lysosomal alpha-D-glucosidase gene" 2:35 2:38||t="test"||cui="C0314604"||tot="Human gene"||ns="-895"
c="amino acid position 645" 2:60 2:63||t="medication"||cui="C0002520"||tot="Amino Acids"||ns="-861"
c="homozygous form" 2:97 2:98||t="treatment"||cui="C0013058"||tot="Dosage Form"||ns="-861"
c="severe infantile phenotype" 2:103 2:105||t="problem"||cui="C1836408"||tot="Severe phenotype"||ns="-913"
c="Pompe's disease" 2:107 2:108||t="problem"||cui="C0017921"||tot="Glycogen storage disease type II"||ns="-1000"
